Pfizer plans cut to $2 billion in costs, Wall Street Journal reports
Pfizer, facing a string of patent expirations and slow earnings growth, plans to cut $2 billion from its costs and ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.